Enfusia, LLC – Trademark Portfolio

Entity Type: 16

Enfusia, LLC holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 8 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include ENFUSIA, SLEEPY BEAR, MUSCLE REHAB, and UNICORN HEART. The owner is based in The Woodlands, TX.

410 South Trade Center Parkway, #A-9

The Woodlands, TX 77385

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Enfusia, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (8 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Enfusia, LLC have?

Enfusia, LLC has 9 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 4 cancelled.

What trademark classes does Enfusia, LLC file in?

Enfusia, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 1 (Chemicals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Enfusia, LLC's most well-known trademarks?

Enfusia, LLC's registered trademark portfolio includes well-known marks such as ENFUSIA, SLEEPY BEAR, MUSCLE REHAB, and UNICORN HEART. These are among 4 currently registered trademarks in the portfolio.

What is Enfusia, LLC's trademark registration success rate?

Enfusia, LLC has a 44% trademark registration rate, with 4 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.